Synchronous apoptosis in established tumors leads to the induction of adaptive immunity

OncoImmunology

Volumn 2, Issue 6, 2013, Pages

  Honeychurch, Jamie ^a   Dive, Caroline ^a   Illidge, Timothy M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; Cancer; Caspase 3; Death switch; HMGB1; Immunogenic cell death

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; DOXYCYCLINE; HEAT SHOCK PROTEIN 90; HIGH MOBILITY GROUP B1 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CELL DEATH; CHROMATIN CONDENSATION; CYTOTOXIC T LYMPHOCYTE; DEATH SWITCH; DENDRITIC CELL; DNA FRAGMENTATION; HUMAN; IMMUNOGENICITY; IMMUNOSTIMULATION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SINGLE DRUG DOSE; T LYMPHOCYTE; TUMOR CELL DESTRUCTION; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR REGRESSION;

EID: 84886944483     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.24501     Document Type: Article

References (10)

1. Henson PM, Hume DA. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol 2006; 27:244-50; PMID:16584921; http://dx.doi. org/10.1016/j.it.2006.03.005
2. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000; 407:784-8; PMID:11048729; http://dx.doi.org/10.1038/35037722
3. Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, et al. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev 2011; 30:61-9; PMID:21249425; http://dx.doi.org/10.1007/s10555-011-9273-4
4. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13:54-61; PMID:17187072; http://dx.doi. org/10.1038/nm1523
5. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13:1050-9; PMID:17704786; http://dx.doi.org/10.1038/nm1622
6. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15:1170-8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028
7. Melis MH, Simpson KL, Dovedi SJ, Welman A, Macfarlane M, Dive C, et al. Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response. Cell Death Differ 2013; 20:765-73; PMID:23412345; http://dx.doi.org/10.1038/cdd.2013.8
8. Welman A, Barraclough J, Dive C. Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2. Nat Protoc 2006; 1:803-11; PMID:17406311; http://dx.doi. org/10.1038/nprot.2006.117
9. Srinivasula SM, Ahmad M, MacFarlane M, Luo Z, Huang Z, Fernandes-Alnemri T, et al. Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits. J Biol Chem 1998; 273:10107-11; PMID:9553057; http://dx.doi. org/10.1074/jbc.273.17.10107
10. Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, et al. Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology 2012; 1:1323-43; PMID:23243596; http://dx.doi.org/10.4161/onci.22009